Don’t aspire to make a living. Let’s aspire to make a difference in the Mandarin/Cantonese-speaking community.” ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the ...

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the ...

Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, ...

An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an ...

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound ...